Are there clinical features of liver disease, myeloproliferative disorder (e.g., blood film changes of unexplained cytopenia, thrombocytosis, or leukocytosis), or another cancer (e.g., cachexia, constitutional symptoms fever, weight loss, night sweats)
References Nature Medicine (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity View Source PMC (2024) Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions View Source Frontiers in Pharmacology (2024) NNMT: a novel therapeutic target for metabolic syndrome View Source PubMed (2021) LC-MS/MS assay for 5-amino-1-methylquinolinium: pharmacokinetic and oral bioavailability study View Source ResearchGate (2021) Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice View Source PMC (2022) Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice View Source NMN.com / Scientific Reports Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise View Source Swolverine 5-Amino-1MQ mechanism, benefits, stacking and cycling guide View Source PMC Subcutaneous drug injection review: pharmacologic considerations View Source CDC Vaccine administration: subcutaneous route (angle/site
borderline results may require additional testing of methylmalonic acid (MMA) and/or homocysteine levels for confirmation
Best For: Enhancing muscle growth, fat loss, and overall rejuvenation
